LIVE EVENTS

The MedBridge Global Podcast

Conversations with the clinicians shaping regenerative and longevity medicine. Real cases, honest opinions and the science behind the headlines.

Watch on YouTube

Latest episodes

Episode 2 · 37 min

The Right to Try program, explained

Vince LiguoriBiotech executive, CEO of L2 Bio and Ageless Biotech

Vince Liguori explains Right to Try, the federal pathway that lets a patient with a potentially life-threatening condition use an investigational product once it has reached at least a phase 2 trial that is active and listed on ClinicalTrials.gov. He sets it apart from Expanded Access, which needs FDA approval for each request, and discloses that he is affiliated with two phase 2 trials, in knee osteoarthritis and Crohn’s disease.

He walks through what the physician has to do: confirm the product qualifies, use a sound informed consent (ideally from the manufacturer), keep the records, explain the approved treatments and their side effects, and look at whether a clinical trial is realistic for the patient. Only an MD or DO can start treatment, with nurse practitioners and PAs helping under their state’s supervision rules, and the drug itself cannot be marked up, though the services around it can be charged for.

Reporting is mandatory, covering serious adverse events and outcomes but no personal health information. Vince and Robert discuss how that data can show manufacturers and the FDA new uses and risks, and close on MedBridge Global’s free three-hour CME course on Right to Try.

Watch on YouTube

Episode 1 · 42 min

From her grandfather’s practice to regenerative podiatry

Dr. Nicole Graf, DPM, FACPM, C.Ped.Podiatrist, Lexington Podiatry

Dr. Nicole Graf started in podiatry at 12, following her grandfather around his practice. She talks with host Robert Rock about opening her own practice in October 2008, as Lehman Brothers collapsed, and how the field has moved from padding and taping to surgery and now to regenerative care.

They cover the newer tools in her clinic (peptides, exosomes, MLS laser and shockwave), when they can spare a patient surgery and when they work best alongside it, and why she says clinicians should learn a peptide properly, from accredited training rather than from people selling it, before recommending one.

She also explains how a foot care line she first made for her own patients became a wholesale product, and previews Toe Tactics, her team’s evening for private podiatry practices at the AAPPM meeting in Fort Lauderdale on Friday 13 November.

Watch on YouTube

Coming up

Upcoming episode

Dr. Serventi

Zephyr Labs

Recording soon

Upcoming episode

Dr. Mark Giovanini

Centre of Life

Recording soon

Clinical conversations

Practitioners talking through real cases: what they tried, what worked and what they would change.

Faculty insight

Time with the MedBridge Global faculty on the questions that rarely fit into a lecture or a paper.

Practice in the real world

Building, running and growing a practice in regenerative and longevity medicine, from the people doing it.